
Ranbaxy Laboratories Ltd, India’s top drugmaker by sales, said its Moroccan unit has started functioning, giving it direct access to a $1 billion pharmaceuticals market. The unit, Ranbaxy’s third in Africa, will also help the company supply products to other north African countries in future, it said on Monday. Ranbaxy’s Africa sales rose 23 per cent to $189 million in 2011, it had said last month. The drugmaker, majority owned by Japan’s Daiichi Sankyo, has sales staff of about 1,000 in 44 African countries and makes drugs in Nigeria and South Africa.
GMT 22:53 2018 Thursday ,13 December
Indian Minister of Trade meets with UAE Ambassador, Chairman of Emaar PropertiesGMT 13:41 2018 Thursday ,06 December
Tyre maker Continental opens lab to extract rubber from dandelionsGMT 15:23 2018 Friday ,30 November
Paper industry around famous Chinese lake to be shut down by 2019GMT 11:13 2018 Sunday ,18 November
Electricx 2018 kicks off with participation of over 20 countriesGMT 16:34 2018 Tuesday ,13 November
Amazon announces new headquarters in New York and WashingtonGMT 16:51 2018 Monday ,12 November
Egypt's exports to Nile basin countries reached EGP 19.9 bln in 2017: CAPMASGMT 08:11 2018 Friday ,09 November
Kaspersky Lab CEO suggests replacing cybersecurity with 'cyber-immunity'GMT 14:00 2018 Thursday ,08 November
Namibian enterprise endeavours to seize opportunities at China import expoMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor